QT
ABVX

Quantbot Technologies’s Abivax ABVX Stock Holding History

Quantbot Technologies’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.6K Sell
312
-20
-6% -$2.26K ﹤0.01% 1675
2026
Q1 		$37K Sell
332
-143
-30% -$16.9K ﹤0.01% 1445
2025
Q4 		$64.1K Buy
+475
New +$51.8K ﹤0.01% 1485

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantbot Technologies's ABVX Position: Q2 2026 in Review

Quantbot Technologies reduced its Abivax (ABVX) stake by 6% in Q2 2026, selling an estimated $2.26K and leaving 312 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Quantbot Technologies first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. The position peaked at $64.1K in Q4 2025. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Quantbot Technologies held 312 shares of Abivax worth $41.6K as of Q2 2026.
  • Quantbot Technologies sold 20 Abivax shares in Q2 2026, an estimated $2.26K.
  • Abivax made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1675 holding.
  • Quantbot Technologies first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • Quantbot Technologies's Abivax position peaked at $64.1K in Q4 2025.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.